MITOXANTRONE AND VP-16 IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA

被引：3

作者：

HO, AD

LIPP, T

EHNINGER, G

MEYER, P

RUCKLE, H

STEINKE, B

KABOTH, W

KORBLING, M

机构：

[1] STADT KRANKENHAUS MUNCHEN SCHWABING,D-8000 MUNCHEN 40,FED REP GER

[2] UNIV TUBINGEN,MED KLIN & POLIKLIN,D-7400 TUBINGEN 1,FED REP GER

[3] UNIV WURZBURG,MED POLIKLIN,D-8700 WURZBURG,FED REP GER

来源：

ONKOLOGIE | 1986年 / 9卷 / 03期

关键词：

D O I：

10.1159/000215990

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：148 / 150

页数：3

共 10 条

[1]

[Anonymous], 1979, WHO HDB REPORTING RE

[2] A PHASE-II TRIAL OF VP-16-213 IN ADULTS WITH REFRACTORY ACUTE MYELOID-LEUKEMIA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY [J].

BENNETT, JM ;

LYMANN, GH ;

CASSILETH, PA ;

GLICK, JH ;

OKEN, MM .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (05) :471-473

[3] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].

BENNETT, JM ;

CATOVSKY, D ;

DANIEL, MT ;

FLANDRIN, G ;

GALTON, DAG ;

GRALNICK, HR ;

SULTAN, C .

BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&

[4] MULTICENTER STUDY ON INTENSIFIED REMISSION INDUCTION THERAPY FOR ACUTE MYELOID-LEUKEMIA [J].

BUCHNER, T ;

URBANITZ, D ;

EMMERICH, B ;

FISCHER, JT ;

FULLE, HH ;

HEINECKE, A ;

HOSSFELD, DK ;

KOEPPEN, KM ;

LABEDZKI, L ;

LOFFLER, H ;

NOWROUSIAN, MR ;

PFREUNDSCHUH, M ;

PRALLE, H ;

RUHL, H ;

WENDT, FC .

LEUKEMIA RESEARCH, 1982, 6 (06) :827-831

[5] MITOXANTRONE IN THE TREATMENT OF RELAPSED AND REFRACTORY ACUTE-LEUKEMIA [J].

EHNINGER, G ;

HO, AD ;

MEYER, P ;

MJAALAND, I ;

OSTENDORF, P ;

SEITHER, E .

ONKOLOGIE, 1985, 8 (03) :146-148

[6]

ESTEY EH, 1983, CANCER TREAT REP, V67, P390

[7]

HO AD, 1985, 14TH P INT C CHEM KY

[8] ETOPOSIDE (VP-16-213) - CURRENT STATUS OF AN ACTIVE ANTICANCER DRUG [J].

ODWYER, PJ ;

LEYLANDJONES, B ;

ALONSO, MT ;

MARSONI, S ;

WITTES, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :692-700

[9]

PACIUCCI PA, 1983, CANCER RES, V43, P3919

[10]

PRENTICE HG, 1984, SEMIN ONCOL, V11, P32

← 1 →